TRIAMTERENE Drug Patent Profile
✉ Email this page to a colleague
When do Triamterene patents expire, and what generic alternatives are available?
Triamterene is a drug marketed by Agnitio, Eywa, Ani Pharms, Cadila, Chartwell Rx, Duramed Pharms Barr, Lannett Co Inc, Mylan, Novartis, Sandoz, Vitarine, Am Therap, Apotex Inc, Pliva, Quantum Pharmics, Rubicon, Watson Labs, and Zydus Pharms. and is included in twenty-four NDAs.
The generic ingredient in TRIAMTERENE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for TRIAMTERENE
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 24 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Clinical Trials: | 8 |
Patent Applications: | 3,680 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIAMTERENE |
Drug Sales Revenues: | Drug sales revenues for TRIAMTERENE |
What excipients (inactive ingredients) are in TRIAMTERENE? | TRIAMTERENE excipients list |
DailyMed Link: | TRIAMTERENE at DailyMed |
Recent Clinical Trials for TRIAMTERENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, Irvine | Phase 4 |
Vanderbilt University | Phase 4 |
West China Hospital | Phase 4 |
Pharmacology for TRIAMTERENE
Drug Class | Potassium-sparing Diuretic |
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Medical Subject Heading (MeSH) Categories for TRIAMTERENE
Anatomical Therapeutic Chemical (ATC) Classes for TRIAMTERENE
US Patents and Regulatory Information for TRIAMTERENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 208360-001 | Jun 29, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus Pharms | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 208360-002 | Jun 29, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Agnitio | TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |